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Fatty acid transport protein 4
is required for incorporation of
saturated ultralong-chain fatty
acids into epidermal ceramides and
monoacylglycerols
Meei-Hua Lin1, Fong-Fu Hsu2, Debra Crumrine3, Jason Meyer3, Peter M. Elias3 &
Jeffrey H. Miner 1,2,4
Fatty acid transport protein 4 (FATP4) is an acyl-CoA synthetase that is required for normal permeability
barrier in mammalian skin. FATP4 (SLC27A4) mutations cause ichthyosis prematurity syndrome, a
nonlethal disorder. In contrast, Fatp4−/− mice die neonatally from a defective barrier. Here we used
electron microscopy and lipidomics to characterize defects in Fatp4−/− mice. Mutants showed lamellar
body, corneocyte lipid envelope, and cornified envelope abnormalities. Lipidomics identified two
lipids previously speculated to be present in mouse epidermis, sphingosine β-hydroxyceramide and
monoacylglycerol; mutants displayed decreased proportions of these and the two ceramide classes that
carry ultralong-chain, amide-linked fatty acids (FAs) thought to be critical for barrier function, unbound
ω-O-acylceramide and bound ω-hydroxyceramide, the latter constituting the major component
of the corneocyte lipid envelope. Other abnormalities included elevated amounts of sphingosine
α-hydroxyceramide, phytosphingosine non-hydroxyceramide, and 1-O-acylceramide. Acyl chain
length alterations in ceramides also suggested roles for FATP4 in esterifying saturated non-hydroxy
and β-hydroxy FAs with at least 25 carbons and saturated or unsaturated ω-hydroxy FAs with at least
30 carbons to CoA. Our lipidomic analysis is the most thorough such study of the Fatp4−/− mouse skin
barrier to date, providing information about how FATP4 can contribute to barrier function by regulating
fatty acyl moieties in various barrier lipids.
Mammalian skin defends against biological, chemical, and mechanical assaults and acts as a barrier to prevent
water loss. Its permeability barrier is established by a series of differentiation events to form the outermost,
cornified layer with three components. (1) The cornified envelope of dead, flattened corneocytes1 is a tough,
water-insoluble protein sac that envelops keratin fibers. (2) Intercellular lipid lamellae form from secreted and
processed lipids from lamellar bodies in granulocytes2. (3) The corneocyte lipid envelope is covalently linked to
involucrin in the cornified envelope, functioning as a scaffold for organizing intercellular lipid lamellae, for intercorneocyte cohesion, or as a semipermeable membrane3.
The lipid lamellae are composed of three major types of lipids—free fatty acid (FFA), ceramide, and cholesterol—at an approximately equimolar ratio4. Ceramide is composed of a fatty acid (FA) and a sphingosine as the
long-chain base. With many possible modifications, ceramides are a large family of lipids5. Epidermal FAs can
contribute to formation of complex lipids or be present in a free form. Several proteins have been implicated in
facilitating the uptake of long-chain FAs (LCFA; C12-C20) in mammalian cells6, including a family of fatty acid
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transport proteins (FATPs), also known as very-long-chain acyl-CoA synthetases7,8. Clinical findings and animal
model studies suggest important roles for these candidate transporters in the skin6.
The FATP family comprises six membrane proteins that mediate uptake of LCFA and very-long-chain FAs
(VLCFA; ≥ C22)9–12. FATPs show diverse subcellular localizations, including plasma and organellar membranes13,14. FATPs exhibit acyl-CoA synthetase activity and are implicated in facilitating uptake of FAs by vectorial
acylation15. The deposition of FATPs in the skin varies substantially16.
We previously identified the wrinkle free mouse that carries a mutation resulting from insertion of a retrotransposon into Slc27a4, the gene encoding FATP417. Mice lacking FATP4 (Fatp4−/− mice) are born with thick,
tight, “wrinkle free” skin and a dysfunctional skin barrier, and they die neonatally due to restricted movements
and dehydration. Fatp4+/− mice are phenotypically normal. Similar phenotypes have been reported in independent Fatp4 mutants18,19. Expression of either a Fatp4 or a Fatp1 transgene in suprabasal keratinocytes restores the
neonatal lethality and rescues the skin phenotype in Fatp4 mutants, demonstrating common substrate preferences, enzymatic activities, and biological functions14,20.
Mutations disrupting human FATP4 are found in patients with ichthyosis prematurity syndrome, which manifests with premature birth, respiratory symptoms, and swollen skin with severe caseosa-like scaling21–23. Surviving
patients recover and show a non-scaly ichthyosis during childhood with dry and pruritic skin and often with
respiratory and/or food allergies24.
Epidermal lipid analyses of Fatp4−/− newborn mice reveal a decreased level of ceramides carrying fatty acyl
chains with 26 or more carbons and an increased level of those with 24 or fewer carbons19,20. Consistent with these
results, Fatp4 mutant epidermis displays an increased amount of FFA likely due to failure of mutant keratinocytes
to activate longer chain FAs to an acyl-CoA form and accumulation of FFA inside cells14.
To investigate how the defect in FFA activation in Fatp4−/− epidermis affects the incorporation of FAs into
ceramides, we performed lipid analyses by thin layer chromatography (TLC) and electrospray ionization-mass
spectrometry (ESI-MS) with free, extractable lipids and protein-bound lipids from newborn epidermis. We identified two lipid types previously speculated to be present in normal mice and identified abnormalities in several
lipid types. Fatp4−/− lipid abnormalities were remedied by suprabasal keratinocyte expression of either a Fatp4 or
a Fatp1 transgene. Consistent with these results, ultrastructural analyses showed that transgene-derived FATP4
or FATP1 could ameliorate most of the defects seen in Fatp4−/− epidermis, including the lamellar body secretory
system and corneocyte lipid envelope formation. Our results provide insights into how FATP4 deficiency alter
fatty acyl moieties in various barrier lipids and subsequently the permeability barrier function of the skin. Our
data also support our previous speculation that FATP4 and FATP1 have overlapping roles in facilitating the usage
of ultralong-chain FA (ULCFA; ≥ C25).

Results

Ultrastructural analyses of Fatp4−/− skin. Ultrastructural analysis revealed curved multilamellar membrane-like structures in the granular and cornified layers of Fatp4−/− newborn mice (Fig. 1b, inset) that are also
present in ichthyosis prematurity syndrome patients25. Fatp4−/− skin also showed multiple abnormalities in the
lamellar body secretory system, including a higher density of lamellar bodies (Fig. 1b) with a decrease in the
lamellar contents (black arrows) vs. controls (Fig. 1a, white arrows). In contrast, fusion of lamellar bodies to the
plasma membrane, secretion of lipid contents to the extracellular space, and post-secretory processing appeared
normal (data not shown). However, the normal-appearing lamellar bilayers were reduced in overall quantity and
accompanied by extensive non-lamellar phase separation compared to controls (Fig. 1e,f). Transgenic FATP4 or
FATP1 expression in mutant suprabasal keratinocytes rescued most of the ultrastructural abnormalities, with
partially corrected lamellar body contents (Fig. 1c,d) and normalization of the quantity and structure of lamellar
bilayers (Fig. 1g,h). Fatp4 mutants showed virtually no visible corneocyte lipid envelope compared to controls
(Fig. 2a’,b’), which was reverted by transgenic expression of FATP4 or FATP1 (Fig. 2c’,d’).
Besides changes in lipid structures, Fatp4 mutant skin showed a significant reduction in thickness of the
protein cornified envelope compared to controls (quantification shown in Fig. 2e). Consistent with this, the
cornified envelope remaining after boiling the skin with an ionic detergent and a reducing agent was smaller in
Fatp4 mutants from embryonic day 16.5 onwards (embryonic day 17.5 shown in Fig. 3d) compared to controls
(Fig. 3a–c). Exogenous FATP4 and FATP1 ameliorated the cornified envelope size defect (Fig. 3e,f). Whereas
FATP1 expression restored the cornified envelope thickness, FATP4 expression increased the cornified envelope
thickness in Fatp4 mutants to a degree that was slightly higher than controls (Fig. 2).
Alterations of unbound lipids in Fatp4−/− epidermis. To resolve how the defect in FA activation in
Fatp4−/− epidermis affected the incorporation of FAs into ceramides, we performed lipid analyses by TLC and
high-resolution ESI-MS with both free, extractable lipids and protein-bound lipids from newborn epidermis.
Consistent with previous reports, our TLC analyses of controls showed five major ceramide bands in the free,
extractable lipid fraction of the epidermis (Fig. 4a). After recovery from the TLC plate for MS, the five ceramide
bands were verified to be: 1) ω-O-acylceramide (Cer(EOS)); 2) a mixture of sphingosine non-hydroxyceramide
with a fatty acyl chain of at least 22 carbons (Cer(NS) ≥ C22) and dihydrosphingosine non-hydroxyceramide
(Cer(NdS)); 3) sphingosine β-hydroxyceramide (Cer(BS)); 4) sphingosine α-hydroxyceramide with a fatty acyl
chain of at least 22 carbons (Cer(AS) ≥ C22); and 5) Cer(AS) with an acyl chain of 16 carbons (Cer(AS)C16).
The Cer(BS) band was previously indicated as phytosphingosine (4-hydroxysphinganine) non-hydroxyceramide
(Cer(NP))26, but with ESI-MS we verified this band to be Cer(BS) as found in human stratum corneum27, in
agreement with original speculation28.
Compared to controls, Fatp4−/− epidermis displayed abnormal patterns of several ceramide classes including
significant reduction in Cer(EOS) and Cer(BS) (Fig. 4a,b). Cer(EOS) contains an amide-linked ULCFA with a
terminal ω-hydroxy group that is further esterified with an additional FA, mainly linoleic acid, and is thought
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Figure 1. Defects in Fatp4−/− lamellar body secretory system ultrastructure. Lamellar body structure ((a–d),
reduced osmium tetroxide post-fixation) and extracellular lipid processing ((e–h), ruthenium tetroxide postfixation) were evaluated by transmission electron microscopy. Typical abnormal curved membrane structures,
seen only in Fatp4−/− epidermis, are shown in the inset in (b). Fatp4−/− lamellar bodies (b) were irregularly
shaped and incompletely filled (black arrows) compared to control (a) and Fatp4−/− rescued with FATP4 (c) or
FATP1 (d) (white arrows show normal lamellar bodies). Secreted lipid in Fatp4−/− was reduced in quantity, as
seen by thin sheets of lamellar lipids ((f), black arrows), and exhibited extensive phase separation (white boxes)
compared to control (e) and Fatp4−/− rescued with FATP4 (g) or FATP1 (h) (white arrows show normally
processed lamellar lipids). Representative images are shown from two mice of each genotype.

to be critical for barrier function29,30. Quantification of Cer(EOS) in two separate studies revealed significant
decreases in Fatp4−/− epidermis. The reduction in Cer(EOS) was accompanied by a significantly reduced level of a
special FA that migrated immediately ahead of the cholesterol band on TLC with a solvent system for polar lipids
(Fig. 4a). This FA band was identified previously to be O-acyl-ω-hydroxy FA (OAHFA)31, a unique type of ULCFA
that constitutes the fatty acyl moiety in Cer(EOS). Its identity was verified here by ESI-MS.
Fatp4−/− epidermis showed a discrete band migrating immediately ahead of Cer(BS) that was barely visible in controls (Fig. 4a). ESI-MS identified this to be Cer(NP). Fatp4−/− epidermis also showed significantly
increased levels of both Cer(AS) ≥ C22 and Cer(AS)C16 (Fig. 4a,b). In contrast, the amount of the band containing Cer(NS) ≥ C22 and Cer(NdS) was reduced significantly in Fatp4−/− epidermis in one study but unchanged
in the other study (Fig. 4b).
Whereas ceramides in control epidermis were resolved into five major bands on TLC, their glycosylated
precursors, glucosylceramides (GlcCer), stored in lamellar bodies of granulocytes were separated into four
bands (Fig. 4a). With ESI-MS we verified the least and the most polar bands of the four to be GlcCer(EOS) and
GlcCer(AS)C16, respectively, as shown previously26,28,32. The other two GlcCer bands were identified to be a mixture of GlcCer(NS) ≥ C22, GlcCer(NdS), and GlcCer(NP), and a mixture of GlcCer(NS)C16, GlcCer(BS), and
GlcCer(AS) ≥ C22. In agreement with the reduced Cer(EOS), Fatp4−/− epidermis also showed a reduced amount
of GlcCer(EOS) (Fig. 4a,b). Quantification of other GlcCer bands did not reveal significant changes in mutants
except reduced GlcCer(NS) ≥ C22, GlcCer(NdS), and GlcCer(NP) mixture (GlcCer 1 in Fig. 4b) in Fatp4−/− epidermis in the same study that showed decreases in Cer(NS) ≥ C22 and Cer(NdS).
In addition to these ceramide and GlcCer classes, mouse epidermal lipids normally contains a less polar ceramide with an ester-linked FA attached to the 1-hydroxyl group of the long-chain base (Fig. 4a)28. By ESI-MS
analysis of bands extracted from the TLC plate we recently identified this ceramide ester to be 1-O-acylceramide
(Cer(1-O-ENS) 33, consistent with a previous report 34. Fatp4 −/− epidermis showed increased levels of
Cer(1-O-ENS) and an unknown ceramide band (Lipid X) that migrated immediately ahead of the GlcCer(EOS)
band (Fig. 4a,b). Fatp4−/− epidermis also showed a dramatically reduced amount of a band that migrated immediately behind the Cer(NS) band (Fig. 4a,b). By MS we identified this to be mainly monoacylglycerol (MAG)35, in
agreement with original speculation32. This band contained Cer(NS)C16 as a minor component, in contrast to a
previous report that it was a major component26. In Fatp4−/− mice expressing either transgenic FATP1 or FATP4
(Fig. 4b), the abnormalities observed in unbound lipids were all remedied.

Alterations of protein-bound lipids in Fatp4−/− epidermis.

TLC analysis revealed two major
protein-bound lipid bands in epidermal extracts from control newborns (Fig. 5a). By MS they were identified
as sphingosine ω-hydroxyceramide (Cer(OS)) and ω-hydroxy FAs (OHFA), the ULCFA that constitutes the fatty
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Figure 2. Defects in ultrastructure of Fatp4−/− corneocyte lipid envelope (CLE) and cornified envelope
(CE). The CLE and CE were examined by transmission electron microscopy as described in Materials and
Methods. The boxed regions in a to d are magnified in a’ to d’, respectively. White arrows indicate typical CLE
morphology: a regular, 4 nm thick lucent band on the external face of the CE (black arrows). Fatp4−/− stratum
corneum (b’) was characterized by no visible CLE and a thin CE compared to control (a’), FATP4- (c’), and
FATP1- (d’) rescued mice. Representative images are shown from two mice of each genotype. CE thickness was
quantified (e) as described in Materials and Methods with the n numbers, standard deviation, and statistical
significance indicated (***P < 0.001). IVL, involucrin promoter.
acyl moiety in protein-bound Cer(OS), in agreement with other reports26,36. Mutants displayed reduced levels
of both protein-bound Cer(OS) and OHFA (Fig. 5b). Another faster migrating FA band reported by others was
detected in some of the Fatp4−/− samples examined but not in controls (right panel of Fig. 5a). The abnormalities
in Cer(OS) and OHFA were remedied by epidermal FATP1 or FATP4 expression (Fig. 5b).

Alterations of FFA and fatty acyl moieties in unbound lipids of Fatp4−/− epidermis.

Free fatty
acid. We previously showed that Fatp4−/− epidermis displayed an increased amount of FFA in the unbound
lipid fraction likely resulting from Fatp4−/− keratinocytes’ failure to activate ULCFA to an acyl-CoA form, with
subsequent accumulation of FFA inside cells14. To investigate the spectrum of the elevated FFA pool and how the
incorporation of FAs into unbound lipids was affected in Fatp4−/− epidermis, unbound lipid extract was separated with solid-phase extraction columns into FFA and various lipid fractions and subjected to high-resolution
ESI-MS (Figs S1, S2, S3). The results showed that the elevated FFA pool (fractions 4 and 5 in Materials and
Methods) in Fatp4−/− epidermis was mainly composed of saturated, non-hydroxy FAs (NHFA) containing 18
to 24 carbons (Fig. 6a) and monounsaturated NHFA containing 20 to 34 carbons (Fig. 6b). The amounts of
both saturated and unsaturated α-hydroxy FAs (AHFA) containing 24 carbons were also dramatically increased
(Fig. 6c). In contrast, the proportions of saturated OHFA (Fig. 6d) and the OAHFA that carried a saturated fatty
acyl backbone (Fig. 6e) were dramatically decreased; examples of OHFA and OAHFA identification are shown
in Figs S4, S5.
Non-hydroxyceramides. MS of fraction 3 of unbound lipids from control epidermis identified Cer(NS) class
carrying an acyl chain of 16 to 32 carbons (Fig. 7a; Fig. S6) and Cer(NdS) class carrying an acyl chain of 24 to 26
carbons (Fig. 7b; Fig. S7). Whereas by TLC the band containing these two ceramide classes in Fatp4−/− epidermis
showed an altered level in only one of our two studies, Cer(NS) displayed altered acyl chain length distribution
by MS. Fatp4−/− epidermis showed a significantly decreased proportion of Cer(NS) with a saturated acyl moiety
containing 25 or more carbons; e.g., two major Cer(NS) species, d17:1/26:0 and d18:1/26:0, were reduced with
4.7- and 3.0-fold changes, respectively. In contrast, Fatp4−/− epidermis showed increased proportions of Cer(NS)
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Figure 3. Defects in Fatp4−/− cornified envelope (CE). The CE was isolated from the dorsal skin of 17.5-day
embryos and viewed under a phase contrast microscope. The CE was smaller in Fatp4 mutants (d) compared to
controls (a–c) but was normalized by transgene-derived FATP4 (e) and FATP1 (f). Representative images are
shown from at least two mice of each genotype. IVL, involucrin promoter.

species containing either a shorter saturated acyl chain or an unsaturated acyl chain. All Cer(NdS) species identified in control epidermis carried a saturated acyl chain, and their levels were decreased in Fatp4−/− epidermis,
especially d18:0/26:0, which showed a 16.0-fold change. The minor lipid Cer(NP) identified in controls comprised
a saturated acyl chain carrying 22 to 26 carbons. The increased Cer(NP) in mutants was reflected in species carrying an acyl moiety of 22 to 24 carbons (Fig. 7c; Fig. S8).
Hydroxyceramides. By TLC Fatp4−/− epidermis showed decreased Cer(BS) and increased levels of two relatively polar ceramide classes, Cer(AS) ≥ C22 and Cer(AS)C16, in the unbound lipid fraction. MS identified
three Cer(BS) species in fraction 3 from controls, all carrying the same ß-hydroxy FA (BHFA) 26:0 but each
with a different long-chain base d16:1, d17:1, or d18:1 (Fig. 7d). Cer(AS) in controls contained an AHFA chain
carrying 16 to 28 carbons (Fig. 7d). All three Cer(BS) species identified shared the same m/z ratios with their
corresponding Cer(AS) isomers, e.g., d18:1/βh26:0 & d18:1/αh26:0 both at an m/z ratio of 692.66 when detected
as [M - H]− ions, making it difficult to assess the exact changes in these ceramides individually in mutants. Of
the other Cer(AS) species that did not have m/z ratios the same as Cer(BS), several were increased in mutants,
such as d18:1/αh22:0 and d18:1/αh26:1. By TLC Fatp4−/− epidermis displayed increased Cer(AS)C16; however,
by MS the changes in amounts of the two individual Cer(AS)C16 species identified were not statistically significant. MS of fraction 3 also revealed Cer(AdS) and Cer(OS) as minor ceramide classes in control (Fig. 7d,e;
Fig. S9). The only Cer(OS) species that carried a saturated acyl chain, d18:1/ωh32:0, was decreased in abundance
in Fatp4−/− epidermis.
ω-O-acylceramide. From fraction 3 of unbound lipids from control, MS also identified the Cer(EOS) class carrying 30 to 36 carbons in the OHFA backbone (Fig. 7f). As reported by others, the OHFA moiety of Cer(EOS)
was esterified mainly with linoleic acid (18:2). The reduced Cer(EOS) in Fatp4−/− epidermis detected by TLC was
attributed to reduced Cer(EOS) species carrying a saturated OHFA backbone and those carrying an unsaturated
OHFA backbone. For example, the two most abundant species in control mice, d18:1/ϖh34:1-18:2 and d18:1/
ϖh32:0-18:2, showed decreased proportions in Fatp4−/− epidermis with 4.8- and 11.9-fold changes, respectively.
Monoacylglyerol. In addition to ceramide classes, MS identified several MAG species in fraction 3 of unbound
lipids from control epidermis. They carried a saturated fatty acyl chain ranging from 22 to 30 carbons with 24:0
being the dominant one (Fig. 8a), consistent with a previous report32. Fatp4−/− epidermis showed dramatic reductions in levels of all MAG species.
1-O-acylceramide. Cer(1-O-ENS), the least polar ceramide in our study, was identified by MS in fraction 2
from control epidermis (Fig. 8b). The increase in Cer(1-O-ENS) level in Fatp4−/− epidermis by TLC was reflected
by the drastically increased levels of many of those carrying 48 or fewer total carbons in their two acyl chains.
In contrast, Fatp4−/− epidermis displayed significantly decreased levels of those with two saturated, longer acyl
chains, e.g., 25:0-d18:1/26:0.
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Figure 4. Alterations in the repertoire of unbound epidermal lipids in Fatp4−/− mice. Free, extractable
lipids from newborn mouse epidermis were co-resolved with standards by TLC (a) and quantified in µg per
mg of dry epidermis (b). The decreased intensities of OAHFA, Cer(EOS), MAG/Cer(NS)C16, Cer(BS), and
GlcCer(EOS) bands and the increased levels of Cer(1-O-ENS), Cer(NP), Cer(AS) ≥ C22, Cer(AS)C16, and
lipid X observed in Fatp4−/− mice were normalized by expression of Fatp1 (Fatp4−/−; Tg(IVL-Fatp1) in a, left;
b, top) and Fatp4 (Fatp4−/−; Tg(IVL-Fatp4) in a, right; b, bottom) transgenes. Lipid standards (a, left) and
unbound epidermal lipid types (arrows) are indicated. Quantification data (b) were obtained from two separate
studies with standard deviation and statistical significance indicated (*P < 0.05; **P < 0.01; ***P < 0.001).
Each study contained 4 each of control, Fatp4−/−, and transgene-rescued mice. Glycerophospholipids (GPL),
sphingomyelin (SM), and the previously reported cholesteryl ester (CE), triacylglycerol (TAG), FAs, and
cholesterol14 are not included in b. GlcCer 1, 2, and 3 refer to the three bands running immediately behind
the GlcCer(EOS) band shown in (a). The TLC results shown in a are from two separate TLC experiments; full
vertical lengths are shown. IVL, involucrin promoter.
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Figure 5. Alterations in the repertoire of protein-bound epidermal lipids in Fatp4−/− mice. Protein-bound
lipids from newborn mouse epidermis were co-resolved by TLC with standards and free epidermal lipids (a)
and quantified in µg per mg of dry epidermis (b). The decreased levels of OHFA and Cer(OS) seen in Fatp4−/−
mice were normalized by the Fatp1 (Fatp4−/−; Tg(IVL-Fatp1) in a, left; b, left) and Fatp4 (Fatp4−/−; Tg(IVLFatp4) in a, right; b, right) transgenes. A faster migrating FA band was seen in some Fatp4−/− samples. Lipid
standards (a, left) and protein-bound epidermal lipids (arrows) are indicated. Quantification data (b) were
obtained from two separate studies with standard deviation and statistical significance indicated (**P < 0.01;
***P < 0.001). Each study contained 6 each of control, Fatp4−/−, and transgene-rescued mutant mice. The TLC
results shown in a are from two separate TLC experiments; full vertical lengths are shown. IVL, involucrin
promoter.

Glucosylceramide. MS on fraction 6 of unbound lipids from control showed glycosylated precursors of most
ceramide species identified in our study (Fig. S10). All three GlcCer(NdS) species (Fig. 9b) and nearly all
GlcCer(EOS) species (Fig. 9f) were reduced in Fatp4−/− epidermis, comparable to the reductions seen in the
corresponding Cer(EOS) species. For example, as the GlcCer(EOS) species d18:1/ϖh32:0-18:2 showed the most
dramatic reduction (6.6-fold changes) in mutants, its corresponding processed Cer(EOS) species also showed the
most dramatic reduction (11.9-fold changes). The proportions of the several GlcCer(AS) species with a distinct
m/z ratio showed similar changes to their corresponding Cer(AS) species except those carrying an acyl chain of
16 carbons (Fig. 9d). In contrast, the changes in abundance of other GlcCer classes did not show good correlation
with those of the corresponding processed forms of Cer. For example, whereas data on GlcCer(NS) in mutants
reflected the significantly decreased proportions of Cer(NS) species with a saturated fatty acyl moiety containing
25 or more carbons, they did not reveal the corresponding increased proportions of Cer(NS) species containing
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Figure 6. Alterations in FFA content in unbound epidermal lipids in Fatp4−/− mice. Pooled fractions 4 and 5
of unbound epidermal lipids of newborns were analyzed by ESI-MS as [M − H]− ions in the negative-ion mode
and quantified in arbitrary units. Fatp4−/− mice showed increased levels of saturated NHFA (C18-C24) and
monounsaturated NHFA (C20-C34) (a,b), decreased levels of saturated OHFA and the OAHFA with a saturated
fatty acyl backbone (d,e), and abnormal levels of AHFA and BHFA (c). Almost all these defects were normalized
by the Fatp1 transgene. Data were obtained from 4 each of Fatp4+/− (controls), Fatp4−/−, and FATP1-rescued
mutants with m/z ratios, standard deviation, and statistical significance shown (*P < 0.05; **P < 0.01;
***P < 0.001). See Materials and Methods for nomenclature.

an unsaturated acyl chain or a shorter saturated acyl chain (Fig. 9a). Also Fatp4−/− epidermis showed decreased
GlcCer(NP) species carrying a saturated acyl moiety with 25 or more carbons, in contrast to unchanged abundance of their corresponding Cer(NP) species (Fig. 9c).
Transgenic FATP1 expression in granulocytes ameliorated nearly all the compositional abnormalities detected
in unbound epidermal lipids of Fatp4−/− mice (Figs 6–9).

Alterations of OHFA and fatty acyl moieties in protein-bound lipids in Fatp4−/− epidermis. MS

of pooled fractions 4 and 5 of protein-bound lipids from control epidermis identified OHFA containing 32 to 36
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Figure 7. Alterations in ceramide content in unbound epidermal lipids in Fatp4−/− mice. Fraction 3 of
unbound epidermal lipids of newborn mice was analyzed by ESI-MS as [M − H]− ions in the negative-ion
mode and quantified in arbitrary units. Fatp4−/− mice showed a shift to the Cer(NS) species with a shorter
saturated acyl chain (a), decreased levels of the Cer(NdS) and Cer(OS) species that contained a saturated
acyl chain (b,e) and of all Cer(EOS) species (f), and increased levels of several species in Cer(NP) and
Cer(AS) (c,d). These defects were all normalized by the Fatp1 transgene. Data were obtained from 4 each of
Fatp4+/− (controls), Fatp4−/−, and FATP1-rescued mutants with m/z ratios, standard deviation, and statistical
significance shown (*P < 0.05; **P < 0.01; ***P < 0.001). See Materials and Methods for nomenclature.

carbons, all carrying one or two unsaturated bonds with ωh34:1 and ωh32:1 being the most abundant (Fig. 10a).
Fatp4−/− epidermis displayed significantly decreased proportions of nearly all OHFA species. MS of fraction 3 of
protein-bound lipids from control epidermis revealed Cer(OS) species carrying a saturated or unsaturated OHFA
chain ranging from 28 to 36 carbons (Fig. 10b), in contrast to the protein-bound OHFA that all carried one or
two unsaturated bonds. Fatp4−/− epidermis displayed diminished levels of all saturated Cer(OS) species, especially d18:1/ωh32:0, which showed an over 170-fold decrease in abundance, and increased or unchanged levels
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Figure 8. Alterations in MAG and 1-O-acylceramide content in unbound epidermal lipids in Fatp4−/− mice.
Fractions 3 and 2 of unbound epidermal lipids of newborn mice were analyzed by ESI-MS in the positive-ion
mode as [M + NH4]+ ions (a) and as [M + H]+ ions (b), respectively, and quantified in arbitrary units. The
decreased levels of MAG species seen in Fatp4−/− mice were all normalized by the Fatp1 transgene (a). Fatp4−/−
mice showed increased levels of many Cer(1-O-ENS) species that carried 48 or fewer total carbons in their two
acyl chains, almost all of which were normalized by the Fatp1 transgene (b). Data were obtained from 4 each of
Fatp4+/− (controls), Fatp4−/−, and FATP1-rescued mutants with m/z ratios, standard deviation, and statistical
significance shown (*P < 0.05; **P < 0.01; ***P < 0.001). See Materials and Methods for nomenclature. MAG
species are listed by their acyl groups. Cer(1-O-ENS) species at the same m/z ratio are listed in descending order
in amount found in controls.

of unsaturated species. Transgenic FATP1 expression in granulocytes normalized nearly all the compositional
irregularities observed in protein-bound epidermal lipids of Fatp4−/− mice (Fig. 10).

Discussion

Fatp4−/− epidermis displayed multiple ultrastructural anomalies in the lamellar body secretory system, a defective corneocyte lipid envelope, and a thinned cornified envelope. These anomalies reflect the lipid composition
changes observed in both the unbound and protein-bound epidermal lipids of Fatp4−/− mice, which normally
constitute the intercellular lipid lamellae and the corneocyte lipid envelope, respectively.
Our TLC and ESI-MS analyses of the unbound fraction of epidermal lipids from normal newborn mice identified five major ceramide classes, Cer(EOS), Cer(NS), Cer(NdS), Cer(BS), Cer(AS), and three minor classes,
Cer(1-O-ENS), Cer(NP), and Cer(OS). Our study is unique in that we identified Cer(BS) and the non-ceramide
lipid MAG, compared to what has been reported previously26,28,32,34. Epidermal Cer(BS) and MAG were first
reported in newborn mice nearly three decades ago based on TLC and chemical reactivities28 but were not verified by MS until now. Our quantification results for unbound lipids showed that Fatp4−/− newborn epidermis displayed dramatically decreased proportions of OAHFA, Cer(EOS), MAG/Cer(NS)C16, Cer(BS), and
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Figure 9. Alterations in GlcCer content in unbound epidermal lipids in Fatp4−/− mice. Fraction 6 of unbound
epidermal lipids of newborn mice was analyzed by ESI-MS as [M − H]− ions in the negative-ion mode and
quantified in arbitrary units. Fatp4−/− mice showed decreased levels of the GlcCer(NS), GlcCer(NdS), and
GlcCer(NP) species that contained a longer saturated acyl chain (a,b,c), of several GlcCer(OS) species (e),
and of nearly all GlcCer(EOS) species (f), and increased levels of several GlcCer(AS) species (d). Almost all
these defects were normalized by the Fatp1 transgene. Data were obtained from 5 each of Fatp4+/− (controls),
Fatp4−/−, and FATP1-rescued mutants with m/z ratios, standard deviation, and statistical significance shown
(*P < 0.05; **P < 0.01; ***P < 0.001). See Materials and Methods for nomenclature.
GlcCer(EOS), and increased proportions of Cer(1-O-ENS), Cer(NP), Cer(AS) ≥ C22, Cer(AS)C16, and the
unknown lipid X. On the other hand, protein-bound lipids from Fatp4−/− epidermis displayed dramatically
decreased proportions in both OHFA and Cer(OS), two major components of the corneocyte lipid envelope.
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Figure 10. Alterations in FA and ceramide content in protein-bound epidermal lipids in Fatp4−/− mice. Pooled
fractions 4 and 5 (a) and fraction 3 (b) of protein-bound epidermal lipids of newborn mice were analyzed by
ESI-MS as [M − H]− ions in the negative-ion mode and quantified in arbitrary units. The decreased levels of
nearly all OHFA species (a) and all saturated Cer(OS) species (b) seen in Fatp4−/− mice were mostly normalized
by the Fatp1 transgene. Data were obtained from 4 each of Fatp4+/− (controls), Fatp4−/−, and FATP1-rescued
mutants with m/z ratios, standard deviation, and statistical significance shown (*P < 0.05; **P < 0.01;
***P < 0.001). See Materials and Methods for nomenclature.
Our analysis of the unbound lipid fraction also revealed alterations in ceramide composition in Fatp4−/− epidermis (See Summary in Table 1). Fatp4−/− epidermis showed profound reductions in production of all Cer(EOS)
species that carried a saturated or unsaturated OHFA backbone of at least 30 carbons. Second, changes in several
other ceramide classes displayed a switch to a composition with decreased abundance of ceramides containing
a saturated acyl chain of at least 25 carbons and with increased abundance of ceramides containing a shorter,
saturated acyl chain. Taken together, our results suggest a less hydrophobic composition of the permeability
barrier structure in Fatp4−/− epidermis. Our data also demonstrate crucial roles for FATP4 in the uptake and/
or activation of saturated NHFA and BHFA with at least 25 carbons and of saturated or unsaturated OHFA with
at least 30 carbons for subsequent synthesis of their corresponding classes of ceramides. For example, FATP4
activates OHFA into a CoA form following the cytochrome P450 CYP4F22-catalyzed ω-hydroxylation of FAs
that have been lengthened by elongation of VLCFA protein 4 (ELOVL4), as hypothesized for the production of
Cer(EOS)25,37,38.
That Fatp4−/− newborn epidermis revealed a switch to a less hydrophobic lipid composition is in agreement
with the defective barrier that we previously reported39. The correlation between lipid composition and skin
barrier is reminiscent of our previous findings that type II diester wax synthesized by sebaceous glands expressing a subnormal level of FATP4 bore fatty acyl moieties of a shorter carbon chain length with a higher degree of
unsaturation. Those changes resulted in an increased fluidity of the sebum and less waterproofing of the fur40.
Data from several other animal models also support the importance of Cer(EOS) in permeability barrier
function and perinatal survival, including mice deficient in ELOVL431,41–43, ceramide synthase 344, patatin-like
phospholipase domain-containing 1 (PNPLA1)45–48, acyl CoA:diacylglycerol acyltransferase 249, α/β hydrolase
domain containing protein 5 (ABHD5)36, stearoyl CoA desaturase 250, and sphingolipid activator protein precursor/prosaposin26. These proteins are all involved in pathways contributing to synthesis or availability of Cer(EOS).
In contrast, animal models that display non-lethal phenotypes and relatively mild barrier defects do not show
changed levels of epidermal Cer(EOS). For example, whereas Fatp4−/− mice showed at least 200% increased transepidermal water loss vs. controls14, Acbp−/− mice51 deficient in acyl-CoA binding protein and Elovl3−/− mice52
lacking the enzyme in elongating fatty acyl chains up to 24 carbons53 showed only ~50% and ~70% increased
transepidermal water loss, respectively.
The identification of Cer(BS) and MAG in this study and of Cer(BS) in our recent report on human stratum
corneum lipids27 is unique. To our knowledge, Cer(BS) and MAG have not been identified in human or other
mammalian skin. Fatp4−/− epidermis showed dramatically decreased proportions of all MAG species carrying
a saturated acyl chain ranging from 22 to 30 carbons. In an in vitro study, a mixture of MAG species containing
a saturated acyl chain ranging from 22 to 26 carbons displayed better occlusive properties than petroleum jelly,
which contains a mixture of hydrocarbons, suggesting a role for MAG in the skin barrier54. It is unlikely that the
epidermal MAG was mainly produced from enzymatic or non-enzymatic lipolysis of triacylglycerols and diacylglycerols. First, our MS analyses revealed that epidermal triacylglycerols in control mice comprised only 46 to
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Table 1. Summarized alterations in fatty acyl chain length and saturation in unbound and protein-bound
epidermal lipids in Fatp4−/− mice. Fractionated unbound and protein-bound epidermal lipids of newborn mice
were analyzed by ESI-MS and quantified as described in Materials and Methods. Changes in lipid abundance
in Fatp4−/− mice compared to controls were summarized in 4 categories based on the chain length (≥C25 or
<C25) and saturation (saturated or unsaturated) of the fatty acyl chains. 1-O-Cer(ENS) species that carry two
saturated acyl chains are categorized as saturated whereas those that carry one or two unsaturated acyl chains
are categorized as unsaturated. aamide-linked acyl chain or acyl backbone; b1-O-linked acyl chain; cassessed
by TLC; dnot for C16; enot for all species; ↑ and ↓, abundance significantly increased or decreased, respectively,
compared to controls; ≅, abundance unchanged compared to controls; ?, abundance unknown; n.a., nonapplicable.

56 carbons in total in the three fatty acyl chains esterified to the glycerol backbone (data not shown), with those
carrying 52 and 54 carbons being the most abundant species, indicating shorter acyl chains in triacylglycerols
than in MAG. Second, the reduced level of MAG in Fatp4−/− epidermis was accompanied by an unaltered level
of triacylglycerols, as shown in our previous study14, implicating no correlation in production between these two
lipids. From where epidermal MAG is derived remains to be investigated.
With a stratum corneum lipid model, it has been reported that the absence of Cer(EOS) or substituting FFA
with shorter chain length ones results in altered lipid lamellae organization and increased permeability55–57.
Effects of perturbed lipid composition on intercellular lipid lamellae organization and/or barrier function have
been revealed in human skin disorders such as atopic eczema and Netherton syndrome58–60, two inflammatory
diseases that manifest with skin barrier defects and allergy features. Some of the lipid composition defects shared
by these disorders were also observed in Fatp4−/− epidermis, including a reduced level of long-chain ceramides
and increased levels of short-chain ceramides, Cer(AS), and monounsaturated FFA.
Changes in abundance of Cer(EOS) and several Cer(AS) ≥ C22 species in mutants were well reflected in their
corresponding GlcCer precursors, but changes in Cer(NS), Cer(NP) and Cer(AS)C16 were not. This suggests that
GlcCer is not the only precursor for these ceramides, consistent with the finding in mouse and human epidermal
lipids that ceramides 2 (Cer(NS)) and 5 (Cer(AS)C16) could also be derived from sphingomyelin packaged in the
lamellar bodies61.
Our data showed that the bound Cer(OS) in Fatp4−/− epidermis was significantly reduced and switched from
a more to a less hydrophobic composition. Our recent data from patients and animal models with mutations
in epidermal lipid synthesis indicate that the corneocyte lipid envelope originates from the limiting membrane
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of lamellar bodies and functions as a bidirectional scaffold for the formation of both intercellular lipid lamellae and cornified envelope25. Thus the abnormalities in bound Cer(OS) likely contribute to the defective barrier in Fatp4−/− mice. Several other animal models showing defective skin barrier also displayed alterations in
ultrastructure of corneocyte lipid envelope or depletion or reduction in bound Cer(OS) levels26,36,41,44,45,62,63. In
12R-lipoxygenase- and ABHD5-deficient epidermis, both saturated and unsaturated bound Cer(OS) species were
dramatically reduced. In contrast, FATP4-deficient epidermis showed depletion in all saturated bound Cer(OS)
species but various changes in unsaturated Cer(OS) species.
With the substrate preference of FATP4 towards saturated NHFA and BHFA (≥C25) and saturated or unsaturated OHFA (≥C30), it is expected that these FFA molecules would accumulate inside Fatp4 mutant keratinocytes
due to an inability of cells to drive the formation and usage of their acyl-CoA derivatives. However, by MS the FFA
that showed the most dramatic elevation in abundance in Fatp4−/− epidermis was unsaturated NHFA (≥C26).
It is possible that this resulted from conversion of saturated NHFAs into unsaturated ones to prevent lipotoxicity
(see below). Alternatively, the accumulation of FFA in Fatp4−/− epidermis could also result from faster delivery of
FAs into cells by an unknown mechanism, increased synthesis of FAs, or increased degradation of other lipids into
FFA. Accumulation of FFA in the skin has also been reported in other animal models. For example, a similar compensatory response to impaired Cer(EOS) synthesis and skin barrier was observed in PNPLA1-deficient mice46.
The observed abnormalities in FFA could change the stratum corneum pH or cause cytotoxicity6. For example,
the decreased level of FFA in Acbp−/− mice is accompanied by an increased pH in the stratum corneum, which
may affect the ionization of FAs, leading to instability of the lamellar membrane and a defective barrier51. In
cultured cells it was reported that saturated LCFA like palmitic acid leads to cell death through lipid remodeling,
oxidative stress, or endoplasmic reticulum stress, whereas unsaturated FFA like oleic acid protects from lipotoxicity64,65. Lipotoxicity can also result from the detergent effect of excess FFA with calcium66.
In summary, we obtained epidermal lipid data by high resolution MS for accurate results, verified the presence
of epidermal Cer(BS) and MAG by MS, and verified the lipid band of Cer(NP) on TLC plates. Our lipidomic analysis also represents the most thorough such study of the permeability barrier in Fatp4−/− mice to date, providing
information about how FATP4 can contribute to barrier function by regulating fatty acyl moieties in various barrier lipids including ceramides and MAG. Understanding how FATP4 regulates lipid metabolism is important for
elucidating the pathogenesis and potential therapies for ichthyosis prematurity syndrome and related disorders.

Materials and Methods

Mice. Fatp4 mutant (Slc27a4wrfr) and human involucrin promoter-driven Fatp4 and Fatp1 transgenic mice
have been previously described14. All animal experiments conformed to the NIH Guide for the Care and Use
of Laboratory Animals and were approved by the Washington University Institutional Animal Care and Use
Committee.
Electron microscopy. The ultrastructural analysis by EM was performed as described25. To visualize the cor-

neocyte lipid envelope and quantify cornified envelope dimensions, skin samples were flash frozen and thawed in
absolute pyridine for 2 h at RT. Following standard fixation, samples were post-fixed in reduced osmium tetroxide
or ruthenium tetroxide before epoxy embedding. The samples were cut on a Leica Ultracut E microtome (Leica
microsystems, Wetzlar, Germany) and imaged on a JEOL 100CX transmission electron microscope (JEOL, Tokyo,
Japan) using a Gatan digital camera. For quantification, the thickness of the cornified envelope was measured in
at least 25 randomly selected positions in 5 random high-powered electron micrographs of the mid stratum corneum from two mice of each genotype. The observer recording these measurements was blinded to the groups.

Isolation of cornified envelope.

Dorsal skin (5 × 5 mm) of embryonic day 16.5 or older mouse embryos
was minced using a razor blade and boiled for 5 min in 200 µl of extraction buffer containing 0.1 M Tris, pH8.5,
2% SDS, 20 mM DTT, 5 mM EDTA, pH8.0. After 10 min of centrifugation, the pellet was resuspended in 100 µl of
extraction buffer, put onto slides, and photographed in phase contrast under a Nikon Eclipse E800 microscope67.

Extraction of epidermal lipids. To obtain free extractable lipids, a lyophilized 10 mg epidermis sample pre-

pared as described14 was soaked in 0.8 ml water in a centrifuge tube for 5 min, and 3 ml chloroform/methanol (1:2,
v:v) were added. Following 30 sec of vortexing and 2 h of shaking at room temperature, an additional 1 ml chloroform and 1 ml water were added. The extraction tube was vortexed for another 30 sec, centrifuged at 2,000 rpm
for 5 min, and the lower, organic layer and the epidermis was each transferred to new tubes. The organic layer was
re-extracted in 1 ml chloroform, 1 ml methanol, and 0.9 ml water with vortexing and centrifugation. The organic
phase was transferred to a vial, dried with a nitrogen evaporator (Organomation Associates, Inc., Berlin, MA),
resuspended in 200 µl chloroform/methanol (2:1), and stored at −20 °C.
To extract protein-bound lipids, the epidermis obtained from the extraction above was depleted of residual
free lipids by shaking for 1 h sequentially in 2 ml chloroform/methanol mix at a 1:1, 1:2, and 0:2 ratio. After discarding the extract, 1 ml 50 mM NaOH in methanol was added to the epidermis followed by incubation at 56 °C
for 2 h with occasional mixing. The reaction was then neutralized with 30 µl of 2 N HCl and extracted in 2 ml
chloroform and 2 ml water. The organic layer was collected in a vial. The upper phase and the epidermis were
reextracted with 2 ml chloroform, and the organic phase was collected and pooled with the previous extract. The
pooled extract was dried, resuspended, and stored as described above.
For quantification of free extractable lipids by MS, lipid standards were added to samples at the beginning of
extraction as follows: 1 µg 1-oleoyl-N-heptadecanoyl-D-erythro-sphingosine (18:1-d18:1/17:0-Cer(1-O-ENS);
860526 from Avanti Polar Lipids, Alabaster, AL) for Cer(1-O-ENS); 3 µg tridecanoic acid (13:0-FA; 1161 from
Matreya LLC, Pleasant Gap, PA) for FAs; 2 µg N-decanoyl-D-erythro-sphingosine (d18:1/10:0-Cer(NS); 1333 from
Matreya) for Cer(NS), Cer(NdS), and Cer(EOS); 11 µg monoheptadecanoin (17:0-MAG; M-159 from Nu-Chek
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Prep, Elysian, MN) for MAG; 1 µg N-alpha-hydroxydodecanoyl-D-erythro-sphingosine (d18:1/αh12:0-Cer(AS);
2042 from Matreya) for Cer(AS), Cer(AdS), Cer(BS), Cer(OS), and Cer(NP); and 0.2 µg D-glucosyl-β11’-N-dodecanoyl-D-erythro-sphingosine (d18:1/12:0-GlcCer(NS); 860543 P from Avanti) for all GlcCer.
For quantification of protein-bound lipids by MS, lipid standards were added to samples at the beginning of
incubation in alkaline solution as the following: 1 µg 17-hydroxyheptadecanoic acid (ωh17:0-OHFA; 1760 from
Matreya) for OHFA; and 1 µg N-alpha-hydroxydodecanoyl-D-erythro-sphingosine for Cer(OS).

Lipid analysis and quantification by TLC. Flexible silica gel 60 plates (Sigma, St. Louis, MO) were
baked at 100 °C for 30 min in an oven prior to use. Free extractable or protein-bound lipids, along with lipid
standards, were applied to plates and resolved in a solvent mixture of chloroform/methanol/water (40:10:1) in a
pre-equilibrated tank until the solvent front moved 7 cm from the bottom of the plate. The plates were air-dried
for 5 min and re-resolved twice in a mixture of chloroform/methanol/glacial acetic acid (95:4.5:0.5) until the
solvent front reached the top of the plate, with 5-min air-dry between the two developments. Resolved plates
were dried, and lipid spots were visualized by spraying with 3% copper acetate in 8% phosphoric acid followed by
charring at 180 °C for 15 min68.
For quantification of lipid types, lipid spots on charred TLC plates were scanned and quantified in ImageJ
(http://rsbweb.nih.gov/ij/) with co-chromatographed standards as follows: Oleic acid (18:1-FA; U-46A from
Nu-Chek) in the range of 0.5 to 4 µg for quantifying OAHFA, and in the range of 0.5 to 8 µg for OHFA; monoolein
(18:1-MAG; 1787-1AMP from Sigma) in the range of 0.5 to 4 µg for MAG; bovine ceramides with NHFA (1056
from Matreya) in the range of 0.265 to 2.12 µg for Cer(1-O-ENS), Cer(EOS), and Cer(NS); bovine ceramides with
AHFA (1056 from Matreya) in the range of 0.235 to 1.88 µg for Cer(AS), Cer(BS), Cer(NP), and lipid X, and in
the range of 0.235 to 3.76 µg for Cer(OS); and bovine galactosylceramides (1128 from Matreya) in the range of
0.5 to 4 µg for all GlcCer bands. The amount of each lipid band was indicated in µg/mg of dry epidermal weight.
Fractionation of lipids.

Fractionation of lipids was performed as previously described with some modifications69. Crude lipids were dried, re-dissolved in 500 µl chloroform, and loaded onto a 3 mL/500 mg
Macherey-Nagel (Duren, Germany) amino Chromabond Sep-Pak column that was pre-washed with 2 × 3 mL
hexane. The column was first eluted with 3 mL hexane:diethyl ether (90:10) (Fraction 1), followed by 3 mL
hexane:ethyl acetate (75:25) (Fraction 2), 3 mL chloroform:methanol (15:1) (Fraction 3), 2 × 3 mL diisopropyl
ether:acetic acid (98:5) (Fractions 4 and 5), 3 mL acetone:methanol (9:1.4) (Fraction 6), 3 mL chloroform:methanol (2:1) (Fraction 7), and finally eluted with 3 mL chloroform:methanol (1:2) (Fraction 8) by gravity. The eluants
were dried in nitrogen, re-dissolved in chloroform (for fractions 1 to 5) or chloroform/methanol (2:1) (for fractions 6 to 8), and stored at −20 °C.

Recovery of lipids from TLC plates. To recover lipid bands from TLC pates, crude or fractionated lipids
were resolved on TLC plates that had been blank-developed in chloroform/methanol (1:1) overnight to remove
impurities. The resolution condition was as described above except that the preparative plate of fraction 2 lipids
was resolved in a mixture of chloroform/methanol/glacial acetic acid (95:4.5:0.5) until the solvent front moved
16 cm from the bottom of the plate and then in a mixture of hexane/diethyl ether/acetic acid (75:25:1) until the
solvent front reached the top of the plate. One of the resolved sample lanes was cut out from the plate and charred
as fiduciary markers. With alignment to the charred lane, lipid bands of interest on the uncharred plate were
marked with a pencil, scraped out with a razor blade, and extracted by vortexing in chloroform:methanol (2:1;
1.5 ml/cm2 gel scraped) for 30 sec followed by centrifugation. The extract was then collected, dried, resuspended
in chloroform or chloroform/methanol (2:1), and stored at −20 °C.
Lipid analysis and quantification by MS.

Lipid analysis was performed on a Thermo Scientific (San
Jose, CA) LTQ Orbitrap Velos mass spectrometer with Xcalibur operating system as described previously27.
Fractionated lipids or lipids recovered from TLC plates were diluted in methanol with 1% NH4OH and loop
injected into the ESI source using a built-in syringe pump that delivered a constant flow of methanol with 1%
NH4OH at a flow rate of 15 µl/min. The ESI needle was set at 4.0 kV, and temperature of the heated capillary was
300 °C. The automatic gain control of the ion trap was set to 5 × 104, with a maximum injection time of 50 ms.
Helium was used as the buffer and collision gas at a pressure of 1 × 10−3 mbar (0.75 mTorr). The MSn (n = 2, 3)
spectra were acquired for structural identification27, and the experiments were carried out with an optimized
relative collision energy ranging from 30–45% and with an activation q value at 0.25, and an activation time at
10 ms to leave a minimal residual abundance of precursor ion (around 20%). The mass selection window for the
precursor ions was set at 1 Da wide to admit the monoisotopic ion to the ion-trap for CID for unit resolution
detection in the ion-trap or high-resolution accurate mass detection in the Orbitrap mass analyzer. Mass spectra were accumulated in the profile mode, typically for 2–10 min for MSn spectra (n = 2–4). Lipid quantitation
was achieved by high resolution ESI-MS measurement on the lipid fractions with internal standards that were
added prior to extraction. All ceramides were analyzed as the [M − H]− ions in the negative-ion mode except for
1-O-acylceramides which were analyzed as the [M + H]+ ions in the positive-ion mode. MAG was detected as the
[M + NH4]+ ions in the positive ion mode. The intensity ratio of individual lipid species to the internal standard
was calculated, normalized to the dry epidermal weight, and the abundance of individual lipid species was plotted
in arbitrary units.

Nomenclature. The following designations and abbreviations recommended by IUPAC (https://www.qmul.
ac.uk/sbcs/iupac/lipid/) are used. The designation of ceramide is in the form of d(or t) long-chain base /FA,
with d denoting a dihydroxy and t denoting a trihydroxy long-chain base. Thus, for example, the sphingosine
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(sphing-4-enine) and sphinganine long-chain bases are designated as d18:1, and d18:0, respectively. Fatty acyl
moieties with or without hydroxyl substituent are denoted as hFA or nFA, respectively, and sphingosine ceramides with α-, β-, or ω-hydroxyl fatty acyl substituent are designated as d18:1/αhFA-Cer, d18:1/βhFA-Cer,
d18:1/ωhFA-Cer, respectively. Therefore, N-α-, N-β-, and N-ω-hydroxy-palmitoyl-sphingosine, for example,
are designated as d18:1/αh16:0-Cer, d18:1/βh16:0-Cer, d18:1/ωh16:0-Cer, respectively. To categorize the ceramide subfamilies, the nomenclature of Motta et al.70, expanded by Robson et al.71 and Masukawa et al.72, was
adopted. The initial letter of the sphingoid bases S, dS, P, and H are used to represent sphingosine, dihydrosphingosine, phytosphingosine, and 6-hydroxysphingosine, respectively, and the FA residues N, A, B, and O represent
nonhydroxylated acyl, α-hydroxyacyl, β-hydroxyacyl, and ω-hydroxyacyl, respectively. Thus, for example, the
d18:0/16:0-Cer, d18:1/βh16:0-Cer, and d18:1/ωh16:0-Cer belong to the Cer(NdS), Cer(BS), and Cer(OS) subfamilies, respectively.

Statistical analysis.

Two-tailed, unpaired Student’s t-tests were used to determine statistical differences in
cornified envelope measurements. Two-way mixed model ANOVA tests were used in quantification of lipids by
TLC and ESI-MS. Differences were considered significant when P < 0.05.

Data Availability

Lipidomics data have been deposited into the EMBL-EBI MetaboLights database73 with the identifier MTBLS1138. The dataset can be accessed at https://www.ebi.ac.uk/metabolights/MTBLS1138.
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